Fin-Ceramica Faenza S.P.A.


Finceramica is a pioneering company in the field of regenerative surgery, developing and marketing biomimetic solutions that transform the landscape of bone and joint regeneration. With a mission to design, develop, and distribute state-of-the-art therapies, the company emphasizes quality, scientific excellence, and social responsibility, aiming to enhance patient quality of life worldwide. Established in 1987 as a spin-off of the CNR, it has a strong global presence, certified quality systems, and a focus on innovative biomaterials and regenerative techniques.

Industries

biopharma
biotechnology
manufacturing

Nr. of Employees

small (1-50)

Fin-Ceramica Faenza S.P.A.

Via Granarolo 177/3, 48018 Faenza (RA), Italy


Products

Porous hydroxyapatite scaffold components for 3D culture and implants

Cylindrical porous hydroxyapatite scaffolds with defined dimensions and pore-size distributions for use in research bioreactors and as implantable bone-regeneration substrates.

Collagen–hydroxyapatite composite scaffold

Multi-layered composite scaffold combining type I collagen and nucleated hydroxyapatite crystals for enhanced biocompatibility and biodegradability in bone tissue engineering.

Web portal for custom implant ordering and collaborative 3D approval

Secure online platform to submit cases, exchange information between stakeholders, and approve 3D implant designs prior to manufacture.


Services

Custom design workflow for patient-specific cranial prostheses with digital surgeon approval, manufacturing of porous hydroxyapatite implants, and clinical support for cranioplasty procedures.

Manufacture and distribution of porous hydroxyapatite and collagen–hydroxyapatite scaffold products intended for orthopedic, spinal and maxillofacial bone regeneration applications.

Provision of perfusion bioreactor starter kits, disposable bioreactor consumables, scaffold adaptors and technical specifications to support reproducible 3D cell culture experiments.

Expertise Areas

  • Biomaterials and scaffold engineering
  • Custom implant design and manufacturing
  • 3D cell culture and tissue engineering
  • Preclinical and clinical evaluation of implants
  • Show More (4)

Key Technologies

  • Porous hydroxyapatite scaffold fabrication
  • High-crystallinity hydroxyapatite production
  • Doped/magnetic hydroxyapatite formulations
  • Collagen–hydroxyapatite composite scaffolds
  • Show More (5)

News & Updates

Participation in the 73rd SINCH Società italiana neurochirurgia congress in Bari, October 2024.

A clinical study demonstrating the efficacy of custom-made porous hydroxyapatite implants saturated with Rifampin to prevent early implant infections.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.